The DOI matches its Crossref record; 80 of the 81 references it cites were found in a registry or an index.
E2F transcriptional repressor complexes are critical downstream targets of p19ARF/p53-induced proliferative arrest
Open accessAbstract
The p16(INK4a)/pRB/E2F and p19(ARF)/p53 tumor suppressor pathways are disrupted in most human cancers. Both p19(ARF) and p53 are required for the induction of senescence in primary mouse embryonic fibroblasts (MEFs), but little is known about their downstream targets. Disruption of E2F-mediated transcriptional repression in MEFs caused a general increase in the expression of E2F target genes, including p19ARF. We detected no contribution of E2F-mediated transactivation in this setting, indicating that a predominant role of endogenous E2F in asynchronously growing primary MEFs is to repress its target genes. Moreover, relief of transcriptional repression by E2F rendered MEFs resistant to senescence induced by either p19(ARF), p53, or RAS(V12). Thus, E2F transcriptional repressor complexes are critical downstream targets of antiproliferative p19(ARF)/p53 signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, mouse, but not human, p19ARF is upregulated by various oncogenes (e.g., Ras and E2F), leading to p53 activation and senescence [125,126].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [126]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 3×
“Then, cells were permeabilized and stained withation of ecotropic retroviruses (Serrano et al., 1997).”
BackgroundThe retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Atmospheric carbon dioxide concentrations over the past 60 million years
Pearson, P. N., & Palmer, M. R. (2000) · Nature · doi:10.1038/35021000 · Cited by 1,771
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521
Ouelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485
Essential role of mouse telomerase in highly proliferative organs
Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270
Research works printed but not linked: 1
- Muller, 2000, The E2F transcription factors, Biochim. Biophys. Acta, 1470, M1
Cited by
Sorted by citations
The RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690
Cellular senescence and tumor suppressor gene p16
Rayess, H., Wang, M. B., & Srivatsan, E. S. (2012) · International Journal of Cancer · doi:10.1002/ijc.27316 · Cited by 825
Tumor suppression by Ink4a-Arf: progress and puzzles.
Lowe, S. W., & Sherr, C. J. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00013-8 · Cited by 699
Kortlever, R. M., Higgins, P. J., & Bernards, R. (2006) · Nature Cell Biology · doi:10.1038/ncb1448 · Cited by 637
Self-citationDivorcing ARF and p53: an unsettled case
Sherr, C. J. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1954 · Cited by 595
Rowland, B. D., Bernards, R., & Peeper, D. S. (2005) · Nature Cell Biology · doi:10.1038/ncb1314 · Cited by 593
Self-citationThe E2F family: specific functions and overlapping interests
Attwooll, C. L., Denchi, E. L., & Helin, K. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600481 · Cited by 584
p53 and E2f: partners in life and death
Polager, S., & Ginsberg, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2718 · Cited by 498
Role of the proto-oncogene Pokemon in cellular transformation and ARF repression
Maeda, T., Hobbs, R. M., Merghoub, T., Guernah, I., Zelent, A., Cordon‐Cardo, C., Teruya‐Feldstein, J., & Pandolfi, P. P. (2005) · Nature · doi:10.1038/nature03203 · Cited by 401
Mechanisms and Regulation of Cellular Senescence
Roger, L., Tomas, F., & Gire, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313173 · Cited by 395
Emerging roles for E2F: Beyond the G1/S transition and DNA replication
Cam, H. P., & Dynlacht, B. D. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00080-1 · Cited by 344
Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin
Gonzalo, S., García-Cao, M., Fraga, M. F., Schotta, G., Peters, A. H. F. M., Cotter, S. E., Eguía, R., Dean, D. C., Esteller, M., Jenuwein, T., et al. (2005) · Nature Cell Biology · doi:10.1038/ncb1235 · Cited by 343
Healing and Hurting: Molecular Mechanisms, Functions, and Pathologies of Cellular Senescence
Adams, P. D. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.021 · Cited by 326
E2F – at the crossroads of life and death
Polager, S., & Ginsberg, D. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.08.003 · Cited by 313
p53 Family and Cellular Stress Responses in Cancer
Pflaum, J., Schlosser, S., & ller, M. M. ⁄. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00285 · Cited by 309
Reversal of Senescence in Mouse Fibroblasts through Lentiviral Suppression of p53
Dirac, A. M. G., & Bernards, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300023200 · Cited by 265
Self-citationCellular senescence and cancer treatment
Schmitt, C. A. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.08.005 · Cited by 254
Taubert, S., Gorrini, C., Frank, S. R., Parisi, T., Fuchs, M., Chan, H., Livingston, D. M., & Amati, B. B. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.10.4546-4556.2004 · Cited by 233
Targeting the RB-E2F pathway in breast cancer
Johnson, J., Thijssen, B., McDermott, U., Garnett, M. J., Wessels, L. F. A., & Bernards, R. (2016) · Oncogene · doi:10.1038/onc.2016.32 · Cited by 201
Self-citationActivation of nuclear factor-kappa B signalling promotes cellular senescence
Rovillain, E. M. I., Mansfield, L., Caetano, C., Álvarez‐Fernández, M., Caballero, O. L., Medema, R. H., Hummerich, H., & Jat, P. (2011) · Oncogene · doi:10.1038/onc.2010.611 · Cited by 205
Regulating the p53 system through ubiquitination
Yang, Y., Li, C.-C. H., & Weissman, A. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207411 · Cited by 184
Regulation of E2Fs and senescence by PML nuclear bodies
Vernier, M., Bourdeau, V., Gaumont-Leclerc, M.-F., Moiseeva, O., Bégin, V., Saad, F., Mes-Masson, A.-M., & Ferbeyre, G. (2011) · Genes & Development · doi:10.1101/gad.1975111 · Cited by 177
Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kineticsPreprint
Aslanian, A., Iaquinta, P. J., Verona, R. I., & Lees, J. A. (2004) · Genes & Development · doi:10.1101/gad.1196704 · Cited by 176
C/EBPβ cooperates with RB:E2F to implement RasV12‐induced cellular senescence
Sebastian, T. B., Malı́k, R., Thomas, S., Sage, J., & Johnson, P. F. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600789 · Cited by 151
Cellular Senescence as the Causal Nexus of Aging
Bhatia‐Dey, N., Kanherkar, R. R., Stair, S. E., Makarev, E., & Csoka, A. B. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00013 · Cited by 149
Dick, F. A., & Dyson, N. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00344-7 · Cited by 142
Zou, X., Ray, D., Aziyu, A., Christov, K. T., Boiko, A. D., Gudkov, A. V., & Kiyokawa, H. (2002) · Genes & Development · doi:10.1101/gad.1033002 · Cited by 146
Shamma, A., Takegami, Y., Miki, T., Kitajima, S., Noda, M., Obara, T., Okamoto, T., & Takahashi, C. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.001 · Cited by 140
A kinase shRNA screen links LATS2 and the pRB tumor suppressorPreprint
Tschöp, K., Conery, A. R., Litovchick, L., DeCaprio, J. A., Settleman, J. E., Harlow, E., & Dyson, N. J. (2011) · Genes & Development · doi:10.1101/gad.2000211 · Cited by 129
Ras-Raf-Arf Signaling Critically Depends on the Dmp1 Transcription Factor
Sreeramaneni, R., Chaudhry, A., McMahon, M., Sherr, C. J., & Inoue, K. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.25.1.220-232.2005 · Cited by 123
Retinoblastoma Tumor Suppressor: Where Cancer Meets the Cell Cycle
Knudsen, E. S., & Knudsen, K. E. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100713 · Cited by 106
Timmers, C. D., Sharma, N., Opavský, R., Maiti, B., Wu, L., Wu, J. S., Orringer, D. A., Trikha, P., Saavedra, H. I., & Leone, G. W. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02147-05 · Cited by 107
Myc-Mediated Proliferation and Lymphomagenesis, but Not Apoptosis, Are Compromised by E2f1 Loss
Baudino, T. A., Maclean, K. H., Brennan, J. A., Parganas, E., Yang, C., Aslanian, A., Lees, J. A., Sherr, C. J., Roussel, M. F., & Cleveland, J. L. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00102-3 · Cited by 101
p53-Dependent and -Independent Functions of the Arf Tumor SuppressorPreprint
Sherr, C. J., Bertwistle, D., den Besten, W., KUO, M.-L., SUGIMOTO, M., Tago, K., Williams, R. T., Zindy, F., & Roussel, M. F. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.004 · Cited by 106
Re-Evaluating Cell-Cycle Regulation by E2Fs
Rowland, B. D., & Bernards, R. (2006) · Cell · doi:10.1016/j.cell.2006.11.019 · Cited by 93
Self-citationMacrophage Migration Inhibitory Factor MIF Interferes with the Rb-E2F Pathway
Petrenko, O., & Moll, U. M. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.11.052 · Cited by 89
Versatile functions of p53 protein in multicellular organisms
Chumakov, P. M. (2007) · Biochemistry (Moscow) · doi:10.1134/s0006297907130019 · Cited by 85
Maehara, K., Yamakoshi, K., Ohtani, N., Kubo, Y., Takahashi, A., Arase, S., Jones, N., & Hara, E. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200411093 · Cited by 83
Therapeutic targeting of replicative immortality
Yaswen, P., MacKenzie, K. L., Keith, W. N., Hentosh, P., Rodier, F., Zhu, J., Firestone, G. L., Matheu, A., Carnero, A., Bilsland, A. E., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.007 · Cited by 82
Petrenko, O., Fingerle‐Rowson, G., Peng, T., Mitchell, R. A., & Metz, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211985200 · Cited by 72
E2F-1 regulates expression of FOXO1 and FOXO3a
Nowak, K., Killmer, K., Gessner, C., & Lutz, W. (2007) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2007.04.001 · Cited by 73
ARF tumor suppression in the nucleolus
Maggi, L. B., Winkeler, C. L., Miceli, A. P., Apicelli, A. J., Brady, S. N., Kuchenreuther, M., & Weber, J. D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.01.016 · Cited by 73
Inoue, K., Mallakin, A., & Frazier, D. P. (2007) · Oncogene · doi:10.1038/sj.onc.1210226 · Cited by 67
p16 and ARF: activation of teenage proteins in old age
Ande, S., & Rudolph, K. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci23437 · Cited by 64
Cell proliferation in the absence of E2F1-3
Wenzel, P. L., Chong, J.-L., Sáenz-Robles, M. T., Ferrey, A., Hagan, J. P., Gomez, Y. M., Rajmohan, R., Sharma, N., Chen, H., Pipas, J. M., et al. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.12.025 · Cited by 66
Chemotherapy response and resistance
Lee, S., & Schmitt, C. A. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00014-x · Cited by 61
Impaired DNA damage checkpoint response in MIF‐deficient mice
Nemajerová, A., Mena, P., Fingerle‐Rowson, G., Moll, U. M., & Petrenko, O. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601564 · Cited by 62
NPAT Expression Is Regulated by E2F and Is Essential for Cell Cycle Progression
Gao, G., Bracken, A. P., Burkard, K. T. D., Pasini, D., Classon, M., Attwooll, C. L., Sagara, M., Imai, T., Helin, K., & Zhao, J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2821-2833.2003 · Cited by 60
Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene
Chen, D., Padiernos, E., Ding, F., Lossos, I. S., & Lopez, C. D. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401536 · Cited by 59
Kandhaya‐Pillai, R., Miró‐Mur, F., Alijotas‐Reig, J., Tchkonia, T., Schwartz, S., Kirkland, J. L., & Oshima, J. (2023) · Aging · doi:10.18632/aging.204743 · Cited by 55
Talluri, S., Isaac, C. E., Ahmad, M. A. E.-R., Henley, S. A., Francis, S. M., Martens, A. L., Bremner, R., & Dick, F. A. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01168-09 · Cited by 57
Sin3B Expression Is Required for Cellular Senescence and Is Up-regulated upon Oncogenic Stress
Grandinetti, K. B., Jelinic, P., DiMauro, T., Pellegrino, J., Rodríguez, R. F., Finnerty, P. M., Ruoff, R., Bardeesy, N. M., Logan, S. K., & David, G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0537 · Cited by 55
ORF73-Null Murine Gammaherpesvirus 68 Reveals Roles for mLANA and p53 in Virus Replication
Forrest, J. C., Paden, C. R., ALLEN, R. D., Collins, J. T., & Speck, S. H. (2007) · Journal of Virology · doi:10.1128/jvi.00111-07 · Cited by 50
Nijwening, J. H., Geutjes, E.-J., Bernards, R., & Beijersbergen, R. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025235 · Cited by 50
Self-citationSmall molecule regulators of Rb–E2F pathway as modulators of transcription
Singh, S., Johnson, J. L., & Chellappan, S. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.07.004 · Cited by 51
Melanomagenesis: Overcoming the barrier of melanocyte senescence
Ha, L., Merlino, G. T., & Sviderskaya, E. V. (2008) · Cell Cycle · doi:10.4161/cc.7.13.6230 · Cited by 50
Oncogene-induced senescence: An essential role for Runx
Terry, A., Cameron, E. R., Neil, J. C., & Kilbey, A. (2008) · Cell Cycle · doi:10.4161/cc.6368 · Cited by 51
Zheng, X., Rao, X., Gómez-Gutiérrez, J. G., Hao, H., McMasters, K. M., & Zhou, H. S. (2008) · Journal of Virology · doi:10.1128/jvi.01708-07 · Cited by 46
ARF Directly Binds DP1: Interaction with DP1 Coincides with the G1 Arrest Function of ARF
Datta, A., Sen, J., Hagen, J., Korgaonkar, C. K., Caffrey, M. S., Quelle, D. E., Hughes, D. E., Ackerson, T. J., Costa, R. H., & Raychaudhuri, P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.8024-8036.2005 · Cited by 46
Hasan, M. K., Yaguchi, T., MINODA, Y., Hirano, T., Taira, K., Wadhwa, R., & Kaul, S. C. (2004) · Biochemical Journal · doi:10.1042/bj20040337 · Cited by 45
RB Reversibly Inhibits DNA Replication via Two Temporally Distinct Mechanisms
Angus, S. P., Mayhew, C. N., Solomon, D. A., Braden, W. A., Markey, M. P., Okuno, Y., Cardoso, M. C., Gilbert, D. M., & Knudsen, E. S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5404-5420.2004 · Cited by 44
Hierarchical Requirement of SWI/SNF in Retinoblastoma Tumor Suppressor-mediated Repression of Plk1
Gunawardena, R. W., Siddiqui, H., Solomon, D. A., Mayhew, C. N., Held, J. D., Angus, S. P., & Knudsen, E. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400395200 · Cited by 45
Penzo, M., Massa, P. E., Olivotto, E., Bianchi, F., Borzı̀, R. M., Hanidu, A., Li, X., Li, J., & Marcu, K. B. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21596 · Cited by 42
Hemmati, P., Normand, G., Verdoodt, B., von Haefen, C., Hasenjäger, A., Güner, D., Wendt, J., Dörken, B., & Daniel, P. T. (2005) · Oncogene · doi:10.1038/sj.onc.1208579 · Cited by 40
MIF loss impairs Myc-induced lymphomagenesis
Talos, F., Mena, P., Fingerle‐Rowson, G., Moll, U. M., & Petrenko, O. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401653 · Cited by 41
AP-1 dimers regulate transcription of the p14/p19ARF tumor suppressor gene
Ameyar‐Zazoua, M., Wisniewska, M. B., Bakiri, L., Wagner, E. F., Yaniv, M., & Weitzman, J. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208424 · Cited by 42
Tavner, F. J., Frampton, J., & Watson, R. J. (2006) · Oncogene · doi:10.1038/sj.onc.1210087 · Cited by 37
At the stem of youth and health
Beltrami, A. P., Cesselli, D., & Beltrami, C. A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.10.005 · Cited by 36
Angus, S. P., Solomon, D. A., Kuschel, L., Hennigan, R. F., & Knudsen, E. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8172-8188.2003 · Cited by 35
Expression of Dmp1 in specific differentiated, nonproliferating cells and its regulation by E2Fs
Mallakin, A., Taneja, P., Matise, L. A., Willingham, M. C., & Inoue, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209750 · Cited by 34
Disruption of E2F signaling suppresses the INK4a-induced proliferative defect in M33-deficient mice
Coré, N., Joly, F., Boned, A., & Djabali, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207998 · Cited by 35
The magnitude of methylmercury-induced cytotoxicity and cell cycle arrest is p53-dependent
Gribble, E. J., Hong, S.-W., & Faustman, E. M. (2005) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20104 · Cited by 34
5‐Aza‐2'‐deoxycytidine reactivates gene expression via degradation of pRb pocket proteins
Zheng, Z., Li, L., Liu, X., Wang, D., Tu, B., Wang, L., Wang, H., & Zhu, W. (2011) · The FASEB Journal · doi:10.1096/fj.11-190025 · Cited by 32
Transcriptional control of the proliferation cluster by the tumor suppressor p53
Brosh, R., & Rotter, V. (2009) · Molecular BioSystems · doi:10.1039/b911416e · Cited by 31
Cheng, P.-H., Rao, X., McMasters, K. M., & Zhou, H. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057340 · Cited by 29
David-Pfeuty, T. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.08.008 · Cited by 29
Activating E2Fs mediate transcriptional regulation of human E2F6 repressor
Lyons, T. E., Salih, M., & Tuana, B. S. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00630.2004 · Cited by 28
Sinkovics, J. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1248 · Cited by 27
Suppression of the p53-Dependent Replicative Senescence Response by Lysophosphatidic Acid Signaling
Kortlever, R. M., Brummelkamp, T. R., van Meeteren, L. A., Moolenaar, W. H., & Bernards, R. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0066 · Cited by 27
Self-citationJin, H., Xie, Q., Guo, X., Xu, J., Wang, A., Li, J., Zhu, J., Wu, X., Huang, H., & Huang, C. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.792010 · Cited by 26
Novel ARF/p53-independent senescence pathways in cancer repression
Chan, C., Gao, Y., Moten, A., & Lin, H. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0766-y · Cited by 25
Douglas, R. M., Farahani, R., Morcillo, P., Kanaan, A., Xu, T., & Haddad, G. G. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00520.2004 · Cited by 26
SUMOylation of p53 mediates interferon activities
Marcos-Villar, L., Pérez-Girón, J. V., Vilas, J. M., Soto, A., de la Cruz-Herrera, C. F., Lang, V., Collado, M., Vidal, A., Rodríguez, M. S., Muñoz‐Fontela, C., et al. (2013) · Cell Cycle · doi:10.4161/cc.25868 · Cited by 25
Timmers, C. D., Sharma, N., Opavský, R., Maiti, B., Wu, L., Wu, J., Orringer, D. A., Trikha, P., Saavedra, H. I., & Leone, G. W. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02147-06 · Cited by 24
TBX2 controls a proproliferative gene expression program in melanomaPreprint
Lu, S., Louphrasitthiphol, P., Goradia, N., Lambert, J., Schmidt, J., Chauhan, J. S., Rughani, M. G., Larue, L., Wilmanns, M., & Goding, C. R. (2021) · Genes & Development · doi:10.1101/gad.348746.121 · Cited by 21
Context-Dependent Requirement for dE2F during Oncogenic Proliferation
Nicolay, B., & Frolov, M. V. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000205 · Cited by 22
Stem cell MicroRNAs in senescence and immortalization: novel players in cancer therapy
Leal, J. A., Feliciano, A., & LLeonart, M. E. (2011) · Medicinal Research Reviews · doi:10.1002/med.20246 · Cited by 22
Genes and pathways involved in senescence bypass identified by functional genetic screens
Roupakia, E., Markopoulos, G. S., & Kolettas, E. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111432 · Cited by 18
Simultaneous expression of MMB-FOXM1 complex components enables efficient bypass of senescence
Kumari, R., Hummerich, H., Shen, X., Fischer, M., Litovchick, L., Mittnacht, S., DeCaprio, J. A., & Jat, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-01012-z · Cited by 13
Signal Transduction Involving the Dmp1 Transcription Factor and its Alteration in Human Cancer
Sugiyama, T., Frazier, D. P., Taneja, P., Kendig, R. D., Morgan, R. L., Matise, L. A., Lagedrost, S. J., & Inoue, K. (2008) · Clinical medicine Oncology · doi:10.4137/cmo.s548 · Cited by 13
RB Family Tumor Suppressor Activity May Not Relate to Active Silencing of E2F Target Genes
Vormer, T. L., Wojciechowicz, K., Dekker, M., de Vries, S., van der Wal, A., Delzenne‐Goette, E., Naik, S. H., Song, J., Dannenberg, J., Hansen, J. B., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3706 · Cited by 13
Genetic and epigenetic alterations in lung tumors from bitransgenic Ki‐rasG12C expressing mice
Floyd, H. S., Jennings‐Gee, J. E., Kock, N. D., & Miller, M. S. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20181 · Cited by 12
Magyar, Z. (2008) · Springer eBooks · doi:10.1007/7089_2007_156 · Cited by 12
Regulation of oncogene-induced cell cycle exit and senescence by chromatin modifiers
David, G. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.21116 · Cited by 10
Targeted discovery tools: proteomics and chromatin immunoprecipitation‐on‐chip
Guezennec, X. L., Brinkman, A. B., Vermeulen, M., Denissov, S., Gazziola, C., Lohrum, M. A. E., & Stunnenberg, H. G. (2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2005.05942.x · Cited by 10
Self-citationSenescence and Cell Cycle Control
Kiyokawa, H. (2006) · Springer eBooks · doi:10.1007/400_001 · Cited by 10
Prindull, G. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.07.009 · Cited by 9
Berns, A. J. M. (2003) · Nature · doi:10.1038/424140a · Cited by 9
Ricci, C., Ambrosi, F., Grillini, M., Serra, M., Melotti, B., Gruppioni, E., Altimari, A., Fiorentino, M., Dika, E., Lambertini, M., et al. (2020) · Journal of Cutaneous Pathology · doi:10.1111/cup.13802 · Cited by 8
E2F1 plays a direct role in Rb stabilization and p53-independent tumor suppression
Palacios, G. F., Talos, F., Nemajerová, A., Moll, U. M., & Petrenko, O. (2008) · Cell Cycle · doi:10.4161/cc.7.12.6030 · Cited by 8
Metadata
- Authors
- Rowland, B. D., Denissov, S. G., Douma, S., Stunnenberg, H. G., Bernards, R., & Peeper, D. S.
- Affiliations
- The Netherlands Cancer Institute (NL)
- Radboud University Nijmegen (NL)
- Corresponding author
- Bernards, René
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2002-07
- Volume
- 2
- Issue
- 1
- Pages
- 55-65
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2149068611
- Cited by
- 120
- References
- 81
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 1 · 2022: 2 · 2021: 5 · 2020: 1 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 3 · 2013: 4 · 2012: 1
- FWCI
- 6.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- KWF Kankerbestrijding
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- p19ARF, p53, cellular senescence, proliferative arrest, RasV12, transcriptional repression, tumor suppressor signaling, senescence resistance
- MeSH terms
- Animals, Cell Division, DNA-Binding Proteins, Fibroblasts, Models, Genetic, Promoter Regions, Genetic, Proto-Oncogene Proteins, Genes, ras, Suppression, Genetic, Transcription Factors, Signal Transduction, Gene Expression Regulation, Neoplastic, Tumor Suppressor Protein p53, 3T3 Cells, Cellular Senescence, Sequence Deletion, Cell Cycle Proteins, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Protein p14ARF, E2F Transcription Factors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review